Überlegungen und Handreichungen zum Thema Suizidalität

Suizidalität bei Krebspatienten

“…Schließlich haben Senf et al [23] das Mortalitätsrisiko durch Suizid von Krebspatienten unter der US-amerikanischen Normalbevölkerung verglichen und einen bedeutsamen Unterschied ermittelt. So war die Häufigkeit bei Krebspatienten, durch Suizid zu sterben, um das 1,4-2,5-Fache erhöht.…”

“…Insbesondere im Jahr nach der Diagnose scheint das Suizidrisiko hoch zu sein [30]. Insgesamt sei jedoch von einer höheren Dunkelziffer auszugehen, da Suizide nur schwer von Unfall, Mord oder unerklärlichem Todesfall abzugrenzen seien [21,23].…”

The significance of the Interpersonal‐Psychological Theory of Suicide in an oncological context—A scoping review

“…Cancer patients report fears about side effects due to treatment, cancer-related pain and physical degradation (Bussmann et al, 2018;Ravaioli et al, 2020). Considering the significance of a cancer diagnosis and the fact that a large number of individuals with a cancer diagnosis suffer from depression (Senf et al, 2016), it is not surprising that suicide is more prevalent in this group than among the general population (Misono, Weiss, Fann, Redman, & Yueh, 2008). Zaorsky et al (2019) report a rate of suicide of 28.6/100,000 person-years in cancer patients.…”

“…Robson et al (2010) suggested that risk factors for suicide relevant to the general population can be extended to individuals with cancer. Nevertheless, a number of specific risk factors are associated with cancer: pain and poor pain control, poor physical functioning, poor cancer prognosis, advanced disease, time since diagnosis, specific chemotherapy agents, lack of social support and perceived burdensomeness toward one's family (Llorente et al, 2005;Noor-Mahomed, Schlebusch, & Bosch, 2003;Robson et al, 2010;Senf et al, 2016). Additionally, tumour localisation has a significant effect on the suicide rate of cancer patients: the highest risk of suicide was observed if the cancer was located in the lung, head and neck, testes or bladder and for Hodgkin lymphoma (SMR: standardised mortality ratio; >5-10) (Zaorsky et al, 2019).…”